Table 1 Patient demographics and molecular information
From: Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
No. of patients | 62 |
No. of female patients | 23 (37%) |
Age ± standard deviation (year) | 53.0 ± 14.8 |
WHO classification grade | |
 II | 28 (45%) |
 III | 21 (34%) |
 IV | 13 (21%) |
IDH mutation status | |
 Wild-type | 33 (53%) |
 Mutant | 29 (47%) |
1p/19q codeletion status for IDH mutant | |
 1p/19q non-codeleted | 17 (28%) |
 1p/19q codeleted | 12 (19%) |